SCHEMBL22857082

SCHEMBL22857082

OC1(Cc2ccccc2F)CCN(S)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GRIN2B Q13224 4/20 0.41
ALDH1A1 P00352 4/20 0.40
CYP2A13 Q16696 1/20 0.38
OPRM1 P35372 2/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
OPRL1 P41146 2/20 0.38
METAP2 P50579 1/20 0.38
GAA P10253 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPK1 P28482 1/20 0.36
ATM Q13315 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11250568 0.84 DPP4 (0.44) MEN1KMT2AGRIN2BALDH1A1CYP2A13
SCHEMBL14840330 0.81 TSHR (0.43) MEN1KMT2AGRIN2BALDH1A1CYP2A13
SCHEMBL22857083 0.81 GRIN2B (0.41) MEN1KMT2AGRIN2BALDH1A1CYP2A13
SCHEMBL17848532 0.80 RIPK1 (0.46) MEN1KMT2AGRIN2BALDH1A1METAP2
SCHEMBL20147361 0.80 OPRM1 (0.44) MEN1KMT2AGRIN2BALDH1A1OPRM1
SCHEMBL10192225 0.80 ALDH1A1 (0.44) MEN1KMT2AGRIN2BALDH1A1TAAR1
SCHEMBL10191864 0.80 ALDH1A1 (0.44) MEN1KMT2AGRIN2BALDH1A1TAAR1
SCHEMBL376474 0.79 OPRL1 (0.54) MEN1KMT2AALDH1A1OPRL1GAA
Hydrochloric Acid SCHEMBL10502200 0.78 POLB (0.55) MEN1KMT2AALDH1A1OPRL1GAA
SCHEMBL11542738 0.77 SIGMAR1 (0.49) OPRM1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10881652-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2021-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10881652-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, BRAF, RAF1 MEN1 653/4885KMT2A 1112/4885GRIN2B 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.